Company helps four out of the top 10 insurance companies automate healthcare administration
PALO ALTO, Calif.–(BUSINESS WIRE)–#AIHealthcareRevolution—Machinify, the company transforming healthcare administration with artificial intelligence (AI), today announced a comprehensive suite of apps designed to address the entire healthcare claims lifecycle, from prior authorization through final payment. Machinify applications are currently in production with four of the top 10 U.S.-based insurance payers.
Machinify’s new app suite, consisting of Machinify Auth, Machinify Audit, and Machinify Pay, debuts at a time when healthcare costs have spiraled out of control. The U.S. has one of the most expensive health systems in the world, where health insurers pay out nearly $4.5 trillion in reimbursements, equating to $13,400 per person. Of this, it is estimated almost $1 trillion is considered wasteful spending, with approximately $500 billion attributed to administrative complexity and pricing failures. Machinify’s software reduces cost and waste while providing patients with more timely access to the care they need.
This new application release comes as Machinify bolsters its go-to-market strategy, having recently announced the appointment of a new Executive Vice President of Sales, Vikas Aligh. Vikas, who will focus on bringing Machinify’s transformative AI solutions to all payers, joins the company with over 20 years of sales leadership experience across SaaS, automation, and AI applications.
“There is an enormous opportunity to leverage AI to change the economics of healthcare. Machinify is leading the way, bringing together purpose-built AI, enterprise-scale software, and deep domain expertise into one connected offering,” said Prasanna Ganesan, Machinify founder and CEO. “Today, our solutions remove hundreds of millions of dollars in administrative costs from the healthcare system, benefiting not only payers, but providers and, most importantly, patients.”
Automating Healthcare Administration
At the foundation of Machinify’s cloud-based software system is a powerful AI engine leveraging the latest in optical character recognition (OCR), natural language processing (NLP), and large language models (LLMs) used in making smart decisions across the claims lifecycle. Trained on billions of claims and millions of medical records to learn the language of medical coding, Machinify’s AI engine is able to validate pre-pay and post-pay requests against complex policies and enable accurate resolution, authorization, and payment. This creates dramatic efficiencies, increasing auth and claim processing accuracy while reducing wait times and frustration for providers and patients.
Today, Machinify’s AI engine powers three applications optimizing the end-to-end healthcare claims lifecycle:
Collectively, Machinify’s apps have delivered hundreds of millions of dollars of annual cost savings, reducing the administrative burden on both payers and providers, while enabling patients to get faster treatment. Machinify also received HITRUST certification, ensuring that all sensitive data is fully protected and is SOC2 compliant.
“Machinify gets rid of administrative inefficiencies that run rampant in the industry, costing payers and patients unnecessarily,” said Dharmesh Thakker, General Partner at Battery Ventures and the lead investor in Machinify. “The healthcare industry has been slow to adopt new technology, but with the results Machinify’s customers have experienced and ease of implementation, payers can’t afford to wait. Doing so will cost them billions in unnecessary costs.”
To learn more about how Machinify is dramatically transforming healthcare administration, please visit www.machinify.com.
About Machinify
Machinify is an AI-powered software company that automates the healthcare claims lifecycle from prior authorization through final payment. The company is headquartered in Palo Alto and is backed by Battery Ventures, Matrix Partners, and GV. Go to www.machinify.com for more information.
Contacts
Stephanie Gnibus
GMK Communications for Machinify
stephanie@gmkcommunications.com
Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…
SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…
BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…
HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…
Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…
Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…